Skip to main navigation
Delcath Systems, Inc. Logo
  • About Us
  • Our Therapy
    • Clinical and Scientific Publications
  • Our Products
    • HEPZATO KIT™
    • CHEMOSAT®
  • Clinical Trials
  • Investors
  • News
  • Contact
    • Careers
  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Financials
    • Annual Reports & Proxy
    • SEC Filings
  • Stock Info
  • Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
  • IR Resources
    • FAQs
    • Analyst Coverage
    • Email Alerts
  • Search Investor Relations
Investor Menu

Now Live on OncLive: All 7 ESMO 2025 Review Episodes

Key Updates in Metastatic Uveal Melanoma

News Releases

March 3, 2026
Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology
PDF Version
February 26, 2026
Delcath Systems Reports Fourth Quarter and Full Year 2025 Results
PDF Version
February 12, 2026
Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call
PDF Version
January 27, 2026
Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
PDF Version
January 21, 2026
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PDF Version
January 9, 2026
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
PDF Version
Delcath Systems, Inc. Logo
  • investorrelations@delcath.com
  • LinkedIn
  • YouTube

Subscribe to Investor Email Alerts

Copyright © 2026 Delcath Systems, Inc. All rights reserved. Privacy Policy Terms of Use Accessibility

Search Investors